FDA Approves LENALIDOMIDE — Accord Healthcare Inc.

# FDA Approves Generic Lenalidomide from Accord Healthcare Inc. Accord Healthcare Inc. received FDA approval for generic lenalidomide (ANDA218872), marking another significant entry into the competitive immunomodulatory drug market and potentially intensifying price competition for this widely-used multiple myeloma and myelodysplastic syndrome treatment. The oral generic approval could substantially reduce patient out-of-pocket costs and expand market accessibility, while putting additional pressure on branded lenalidomide revenues and other competing manufacturers in the multiple myeloma therapeutics space.